GlassScriptPhysician profile
Glenn J Donovan
NPI 1700950839
$2,068.46
in general payments reported to CMS, 2019-2025
15 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,403 · 2020: $17.63 · 2021: $155 · 2022: $17.96 · 2023: $67.14 · 2024: $85.57 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $903.88 | 2019 | |
| Globus Medical, INC. | $238.13 | 2025 | Senza |
| Advanced Oxygen Therapy INC. | $235.67 | 2019-2021 | |
| Medtronic Vascular, INC. | $162.98 | 2019 | |
| Paratek Pharmaceuticals, INC. | $143.32 | 2023-2025 | Nuzyra |
| Acell, INC. | $124.32 | 2019 | |
| Smith+Nephew, INC. | $56.15 | 2019-2020 | |
| Stryker Corporation | $39.35 | 2021 | |
| Medtronic, INC. | $33.42 | 2025 | Minimed 780g |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.05 | 2023 | Trulance, Xifaxan |
| Tactile Systems Technology INC | $29.09 | 2024 | Flexitouch Plus, Entre Plus |
| Redhill Biopharma INC. | $20.86 | 2021 | |
| Sanara Medtech INC. | $19.01 | 2021 | |
| Sebela Pharmaceuticals INC. | $17.96 | 2022 | |
| Lilly USA, LLC | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Donovan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.